| J9271 | Injection, pembrolizumab, 1 mg | 5,200 | $40 | $208.1K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 4,500 | $40 | $171.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 160 | $110 | $17.1K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 760 | $20 | $16K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 100 | $140 | $13.4K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 70 | $130 | $9.6K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 30 | $170 | $5.9K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 70 | $60 | $3.8K |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community… | 20 | $210 | $3.8K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 220 | $10 | $2.8K |